Dr Elena Crisà/touchhaematology.com
Oct 19, 2025, 11:27
Future Leader 2025 – Dr Elena Crisà on Precision Medicine in Haematology
TMC (Touch Medical Communications) shared a post on LinkedIn:
“Future Leader 2025 – Dr Elena Crisà on Precision Medicine in Haematology
In this inspiring interview, Dr Elena Crisà (Candiolo Cancer Institute, Italy) discusses how precision medicine is transforming the diagnosis and treatment of acute myeloid leukaemia ( AML ).
From clinical trials to patient-centred care, Dr Crisà shares what drives her work and why aligning treatment with individual values is essential.”
Read the full feature here.
Stay updated with Hemostasis Today.
-
Jul 5, 2026, 22:51Shahzaib Akram: What Are We Actually Seeing When a Sickling Test Goes Positive?
-
Jul 5, 2026, 21:474 Tips for Exercising with A Bleeding Disorder – Haemophilia Foundation Australia
-
Jul 5, 2026, 21:06Heghine Khachatryan: Toward Personalized Management of Glanzmann Thrombasthenia
-
Jul 5, 2026, 21:06Priyanka Kumari: IV Fluids and Isotonic Solution
-
Jul 5, 2026, 21:05Ahmed Rizq: Would You Thrombolyse a Stable Patient?
-
Jul 5, 2026, 21:03Emmanuel Obeng Ofori: Diagnosing Anaemia – Why Treating the Root Cause Matters More Than Simply Raising the Haemoglobin
-
Jul 5, 2026, 21:02Mohit Koladia: The Pharmacist’s Role in Stroke Prevention for Atrial Fibrillation
-
Jul 5, 2026, 20:22J. Meireles-Brandao: Exploring the Approach to Thrombophillias
-
Jul 5, 2026, 20:13Kavya Keerthana: The Platelet Count Everyone Calls ‘Reactive’ Until It Isn’t